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A B S T R A C T
Introduction: Preeclampsia (PE) is a pregnancy related endothelial disease characterized by hypertension and
albuminuria. Postpartum endothelial dysfunction often persists in these women. We postulate that in women
with a history of PE reduced endothelial dependent vasodilation coincides with attenuated kidney function, as
both reﬂect endothelial dysfunction.
Methods: We assessed endothelial and kidney function in women with a history of PE (n= 79) and un-
complicated pregnancies (n= 49) at least 4 years postpartum. Women with hypertension, diabetes or kidney
disease prior to pregnancy were excluded. Brachial artery ﬂow mediated dilatation (FMD) was measured and
analysed by a custom designed edge-detection and wall-tracking software. We measured albumin and creatinine
levels in a 24-h urine sample and calculated glomerular ﬁltration rate (GFR) by CKD-EPI.
Results: Women with a history of PE had lower FMD but comparable GFR and albumin creatinine ratio (ACR)
compared with controls. Independent of obstetric history, in both controls and women with a history of PE
respectively, GFR (r= 0.19, p= 0.17 and r= 0.12, p= 0.29) and albumin creatinine ratio (r= 0.07, p= 0.62
and r= 0.06 p= 0.57) did not correlate with FMD.
Conclusion: At least 4 years after pregnancy, women with a history of PE demonstrated decreased ﬂow mediated
dilatation when compared to healthy parous controls. In this study, decreased ﬂow mediated dilation however
did not coincide with decreased kidney function.
1. Introduction
Preeclampsia (PE) is a pregnancy induced endothelial disease that is
characterized by hypertension and albuminuria. Despite the low in-
cidence of 2–8% of pregnancies complicated by PE, it has great impact
on maternal and foetal morbidity and mortality (Ghulmiyyah and Sibai,
2012). Worldwide, PE accounts for 14% of maternal deaths, resultantly
PE is the second most common cause of maternal death after post-
partum haemorrhage (Organization, WH, 2014; Say et al., 2014). In
women with a history of PE, endothelial function, as measured by ﬂow
mediated dilatation (FMD) is decreased. It improves in the ﬁrst few
weeks postpartum but fails to normalize in the ﬁrst years after gestation
when compared with FMD levels measured in healthy parous controls
(Higashi, 2015; Kuscu et al., 2003; John et al., 2001). This indicates
only partial reversal of the endothelial dysfunction after a pregnancy
complicated by PE. Women with an early onset PE or recurrent PE have
more pronounced endothelial dysfunction after pregnancy suggesting
that attenuated endothelial function parallels severity of disease in
pregnancy (John et al., 2001). Endothelial dysfunction during a preg-
nancy complicated by PE also aﬀects kidney function. Kidney dys-
function, reﬂected by either albuminuria or decreased glomerular ﬁl-
tration rate (GFR), can persist over a period of time after delivery, but
most women with a history of preeclampsia maintain good kidney
function (Lafayette et al., 1998; Hussein and Lafayette, 2014). None-
theless, a subgroup of women have persistently decreased kidney
function long after their complicated pregnancy (Spaan et al., 2009;
Sarah et al., 2010). It may be that, in these women, endothelial dys-
function is reﬂected in both attenuated kidney function and endothelial
dependent ﬂow mediated vasodilation (Deckert et al., 1989). In this
study we tested the hypothesis that in women with a history of pre-
eclampsia, kidney function correlates with endothelial dependent ﬂow
mediated vasodilation. To this end, we measured endothelial function
by brachial ﬂow mediated dilation and kidney function by evaluating
24 h micro albuminuria and GFR, at least 4 years postpartum, in both
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women with a history of PE and in a control group of women who had
normotensive pregnancies.
2. Methods
In this study, we used a database of women with a history of PE
(n= 99) who had been tested several years after their pregnancy
complicated by preeclampsia. Healthy parous controls (n= 49),
women with normotensive pregnancies, were recruited through ad-
vertisement. All women included were of Northern European Ancestry
and completed a follow-up program in 2011. Evaluations were per-
formed in the non-pregnant state at least 4 years after the ﬁrst (index)
gestation postpartum. The study was approved by the Medical Ethics
Committee of the Radboud University Medical Centre Nijmegen (CMO
2010/245). All women gave written informed consent. Preeclampsia
was deﬁned according to the criteria of the Report of the National High
Blood Pressure Education Program Working Group on High Blood
Pressure in Pregnancy (Am. J. Obstet. Gynecol., 2000). Neonatal birth
weight centile was determined using Dutch reference values for birth
weight, corrected for gender and parity (Nederland Spr, 2011).
Women were instructed to fast overnight, abstain from alcohol and
caﬀeine for 16 h and not to perform any exercise in the 24 h preceding
the measurements. A 24-h urine sample was collected. Upon arrival
(body) characteristics were measured and a full medical history was
taken. A venous blood sample was taken for measurement of kidney
function. Serum creatinine and urine creatinine were measured by an
enzymatic colorimetric method (Architect, Abbott Laboratories, Abbott
Park, IL, USA) and urine albumin by immunonefelometry (Dade
Behring BN II Nefelometer, Siemens, Mississauga, Canada). We esti-
mated GFR by the CKD-EPI equation for female and Caucasian, in
which both formulas are dependent on serum creatinine. When serum
creatinine was below or equal to 0.7 mg/dl, we used 144 × (serum
creatinine / 0.7)−0.329 × 0.993age. When serum creatinine was above
0.7 mg/dl we used 144 × (serum creatinine / 0.7)−1.209 × 0.993age.
Albuminuria was quantiﬁed by the albumin creatinine ratio (ACR) in
the 24-h urine sample. Blood pressure was recorded for a period of
30 min at 3-min intervals using a semiautomatic oscillometric device in
half-sitting position. Median values of 9 subsequent recordings were
used for analysis. Measurements of FMD were taken as previously de-
scribed by Scholten et al. (2014). All FMD measurements were per-
formed under standardized conditions in a temperature controlled
(± 20 °C), quiet room. Before starting the protocol, subjects rested for
at least 15 min, the arm was in an extended position at ~80° from the
torso and patients were in supine. An automated system ensured a rapid
inﬂation and deﬂation of the cuﬀ (D.E. Hokanson, Bellevue, WA), with
cuﬀ size recommended for the arm circumference and positioned
around the forearm, a few centimetres distal to the olecranon. A 10-
MHz multifrequency linear array probe attached to a high resolution
ultrasound machine (T3000, Terason, Burlington, MA) was used to
image the brachial artery in the distal third of the upper arm, 2–5 cm
above the antecubital fossa.
The continuous Doppler velocity was simultaneously measured with
the ultrasound at an angle of< 60°. First a 1 min baseline recording of
brachial artery diameter velocity was measured. Thereafter the forearm
cuﬀ was inﬂated (> 200 mm Hg) for 5 min. The diameter and ﬂow
assessments were done 30 s before deﬂation until 3 min after deﬂation.
FMD analysis was done by custom designed edge-detection and wall-
tracking software, independent of investigator bias. Peak diameter was
automatically detected according to an algorithm that is described in
detail elsewhere (Black et al., 2008). Reproducibility of FMD using this
semi-automated software possesses a coeﬃcient of variation of
6.7–10.5%.
2.1. Statistical analysis
All analyses were performed using SPSS version 21.0, property of
IBM and supplied by Maastricht University. Data were expressed as
group means and standard deviation or medians and interquartile
ranges. A p-value < 0.05 was considered to indicate a statistical sig-
niﬁcant diﬀerence. An unpaired t-test was used to analyses diﬀerences
between groups with normally distributed data. For non-normal dis-
tributed data, we used the Mann-Whitney U test. Dichotomic data was
analysed with a chi square test. Bivariate correlations were analysed by
Spearman's test. A logistic regression was performed to correct for
months postpartum, age and the use of antihypertensive drugs.
3. Results
A total of 128 women, 79 with a history of preeclampsia and 49
with an uncomplicated pregnancy were selected after exclusion of
women who had hypertension (n= 18), diabetes mellitus (n= 5) prior
to the pregnancy. None had a known history of kidney disease prior to
pregnancy (Fig. 1).
Three women with a history of preeclampsia and two healthy
parous controls did not collect 24 h urine. We did not estimate micro-
albuminuria in these subjects. Table 1 shows the characteristics of the
Fig. 1. Flowchart.
Table 1
Baseline characteristics of women with a history of preeclampsia and uncomplicated
pregnancy.
Uncomplicated
pregnancy
n= 49
History of
preeclampsia
n= 79
p-value
Age (y) 39 ± 4 35 ± 4 < 0.001
BMI (kg/m2) 23 ± 3 25 ± 6 0.067
Smoking (%) 5 (10%) 8 (9%) 0.605
Primiparity 5 (10%) 25 (33%) 0.009
Gestational age at
delivery (weeks)
39 ± 2.3 33 ± 4.5 < 0.001
Birth weight (gram) 3358 [3012–3745] 1786
[1036–2715]
< 0.001
Birth centile 44 [20–65] 24 [5–34] < 0.001
Months postpartum 96 [70–119] 59 [47–66] < 0.001
Antihypertensive drugs
(%)
0 7 (9%) 0.031
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study group. Women with a history of PE were on median 4.4 years
postpartum, delivered at an earlier gestational age and gave birth to
smaller infants at lower birth weight centile compared with healthy
parous controls. Controls were on median 8.7 years postpartum and
older compared to women with a history of preeclampsia. Women with
a history of PE delivered in 53% of cases before 34 weeks gestation and
58% had a child small for gestational age, deﬁned as a growth below
the 10th centile. FMD and GFR and micro-albuminuria were similar in
women with PE with or without SGA and in women with PE and a
delivery before or after 34 weeks pregnancy (see supplemental tables).
Women with a history of preeclampsia had lower FMD (6.6 ± 3.0
vs 9.0 ± 3.6%; p 0.001) and higher systolic blood pressure (114 ± 11
vs 110 ± 10 mm Hg; p 0.005) but similar GFR (105 ± 16 vs
99 ± 14; p 0.55) and micro-albuminuria (0.6 [0.3–1.3] vs 0.5
[0.4–1.1]; p 0.92) when compared with women with an uncomplicated
pregnancy (Table 2).
Women with a history of PE also used more antihypertensive drugs
(0% vs 8.8%, p 0.031). Baseline diameter values of the brachial artery
between groups were comparable (p 0.76). In both women with a
history of PE and controls respectively, FMD did not correlate with
either albumin creatinine ratio (r= 0.07, p= 0.62 and r = 0.07
p= 0.51) or GFR (r = 0.19 p= 0.17 and r= 0.15, p= 0.19) (Figs. 2
and 3).
4. Discussion
Women with a history of preeclampsia have decreased FMD, sug-
gesting endothelial dysfunction, but demonstrate similar GFR and ur-
inary albumin loss when compared to healthy parous controls. In con-
trast to our expectations, we observed no correlation between FMD and
kidney function. Interestingly a correlation has been found between a
decreased FMD and proteinuria at 5 years postpartum in women with a
history of preeclampsia (Aykas et al., 2015). We were, however, unable
to ﬁnd a correlation between GFR and FMD on the one hand and mi-
croalbuminuria and FMD on the other. This could be a result of a dif-
ferent postpartum interval, chosen exclusion criteria or diﬀerences in
the severity of the gestational disease. A sub-analysis of women with an
increased ACR and decreased FMD was not possible due to the small
number of women.
Damaged endothelium frequently results in altered permeability of
vessels, in the glomerulus, this is clinically apparent as albuminuria
(Salmon and Satchell, 2012). The absence of micro albuminuria, a
variable that is considered to reﬂect endothelial disease, particularly if
GFR is normal, might suggest that there is endothelial recovery in the
kidneys, but that women with a history of preeclampsia could have
constitutional reduced FMD or a higher susceptibility for endothelial
dysfunction as compared to healthy parous controls. Chronic kidney
disease in itself is associated with a decreased endothelial function as
measured by FMD (Malyszko, 2010; Verbeke et al., 2007; Verbeke
et al., 2011). Even though decreased FMD and microalbuminuria both
reﬂect endothelial dysfunction they may reﬂect diﬀerent aspects of
endothelial function. Alternatively the endothelial function as assessed
by micro-albuminuria may follow a diﬀerent recovery rate than en-
dothelial function expressed with FMD. The vaso homeostasis of our
endothelium is primarily eﬀectuated by nitric oxide which is released in
response to increased shear stress caused by changes in blood ﬂow (Boo
and Jo, 2003). When the endothelium loses its ability to maintain the
delicate balance of circulatory, haemostatic and immunological
homeostasis, it becomes vulnerable for the invasion of lipids and leu-
kocytes at locations where lesions occur. A dysfunctioning en-
dothelium, and a decreased availability of nitric oxide, is considered the
ﬁrst step in the development of atherosclerosis and subsequently car-
diovascular disease. Although time consuming, FMD is a useful non-
invasive reproducible ultrasonographic technique that has been used in
many clinical studies and is an indicator of vascular health (Thijssen
et al., 2011; Atkinson and Batterham, 2015). During preeclampsia, ﬂow
mediated dilatation is decreased, indicating endothelial dysfunction
(Guimaraes et al., 2014; Dorup et al., 1999; Vieira et al., 2013;
Weissgerber, 2014). During pregnancy, this dysfunction is paralleled by
increased permeability leading to extravasation of ﬂuid and oedema
formation on the one hand, and the loss of albumin due to glomerular
endotheliosis on the other. The endothelium not only seems to be at-
tenuated during the pregnancy aﬀected by preeclampsia, but this seems
to persist until several years postpartum (John et al., 2001; Hamad
et al., 2007; Paez et al., 2009; Goynumer et al., 2013; Murphy et al.,
2014). The relative diﬀerence of FMD between women with a history of
preeclampsia and controls is generally between 20 and 58%, which is
similar in our study (Hamad et al., 2007; Paez et al., 2009; Goynumer
Table 2
Kidney function, endothelial function and blood pressure in women with a history of
preeclampsia and uncomplicated pregnancy. Data presented were adjusted for months
postpartum, age and use of antihypertensive drugs.
Uncomplicated
pregnancy
n = 49
History of
preeclampsia
n= 79
p-value
GFR (ml/min/1.73m2) 98 ± 14 105 ± 16 0.55
Albumin creatinine ratio
(g/mmol)
0.5 [0.4–1.1] 0.6 [0.3–1.3] 0.92
Flow mediated dilation
(%)
9.0 ± 3.6 6.6 ± 3.0 0.001
Baseline diameter a.
brachialis (mm)
3.0 ± 0.3 3.0 ± 0.4 0.76
Systolic blood pressure
(mm Hg)
110 ± 10 114 ± 11 0.005
Diastolic blood pressure
(mm Hg)
71 ± 7 72 ± 8 0.09
Fig. 2. Correlation between albumin creatinine ratio and ﬂow
mediated dilatation (ACR/FMD) in women with a history of
preeclampsia and uncomplicated pregnancy. The unbroken
trend line represents de women with preeclampsia and the da-
shed trend line represents controls.
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et al., 2013; Sandvik et al., 2013a).
Endothelial dysfunction is also expressed as decreased kidney
function during a pregnancy complicated by preeclampsia and there-
after. Women with preeclampsia exhibit increased albuminuria during
pregnancy and have a 4 to 5 times increased risk of end stage kidney
disease in later life (Vikse, 2013). Some women maintain decreased
kidney function after preeclampsia. This could be either due to un-
diagnosed pre-existing kidney disease, higher susceptibility or con-
comitant renal risk factors in these women to develop chronic kidney
disease or due to irreversible kidney damage as a consequence of pre-
eclampsia. Most studies on kidney function after preeclampsia have
insuﬃcient data on pre-pregnancy GFR or albuminuria values to de-
termine a possible subclinical undetected pre-existing kidney dysfunc-
tion (Sarah et al., 2010). Despite the fact that we excluded women with
known pre-existing kdiney disease, we cannot rule out subtle abnorm-
alities in kidney function. Nonetheless, the observed kidney function
does not support the thought that our population studied suﬀered from
kidney dysfunction. Even though some studies show decreased kidney
function after pregnancy complicated by preeclampsia (Bar et al.,
1999), others do not (Sandvik et al., 2013b; Lampinen et al., 2006).
Nonetheless, as a group, women with a history of preeclampsia have an
increased risk of end stage kidney disease, even when corrected for
common risk factors and confounders such as pre-existing kidney dis-
ease, rheumatic disease, hypertension, or diabetes mellitus before
pregnancy (Ras et al., 2013). Similarly, ﬂow mediated dilatation ap-
pears to be diminished in several, but not all studies in women with a
history of PE (John et al., 2001; Sandvik et al., 2013b). It is important to
note that all these studies are heterogeneous in nature due to multiple
factors namely, measurements at a certain point in time after delivery,
diﬀerences in severity of preeclampsia and in treatment during preg-
nancy, but also because of diﬀerent health policies instituted after
pregnancy. It is therefore diﬃcult to draw conclusions based on such
heterogeneous studies on the pattern of recovery. Endothelial dys-
function, either expressed by albuminuria or decrease in ﬂow mediated
vasodilation, has been investigated in several prospective studies in
relation to cardiovascular disease (Ras et al., 2013; Frick et al., 2005;
Maruhashi et al., 2013). Meta-analysis detailed that an absolute in-
crease in FMD by 1% decreased the risk of a cardiovascular event in the
upcoming 8 years by 13% (Inaba et al., 2010). Moreover, a two-fold
increase in albuminuria, another predictor of cardiovascular mortality,
is associated with 29% more risk for cardiovascular mortality (Hillege,
2002). Therefore it seems prudent to evaluate ﬂow mediated dilation
and micro-albuminuria in the follow-up of women with a history of
preeclampsia as both are considered markers indicating the risk of fu-
ture cardiovascular disease.
There are some shortcomings of this study that need to be ad-
dressed. First, on the one hand, our population contains predominantly
women with either early onset disease or concomitant small for
gestational age infancy, both indicators considered to represent more
severe disease. This may limit generalizability of our results to all
women with a history of preeclampsia. On the other hand, the results
might be an underestimation of the prevalence of chronic kidney dis-
ease as we excluded women with pre-existing diabetes mellitus, hy-
pertension and kidney disease. Second, the cross-sectional nature of this
study may have aﬀected observations. It may be that pace in recovery
from pregnancy may be diﬀerent in the kidney as compared to the
endothelium in general, reﬂected by FMD, which could only be de-
tected by repeated measures over time. Lastly, the age diﬀerence be-
tween groups can have an eﬀect endothelial function. Endothelial
function and its regenerative capacity decrease over time and age re-
lated adaptation can gradually be seen in women form the 4th decade
of life onwards, and after menopause these changes are even more
pronounced (Greenwald, 2007; Harvey et al., 2016; Higashi et al.,
2012; Lakatta, 2003; Celermajer et al., 1994; Juonala et al., 2008;
Jensen-Urstad and JJ, 2001; Black et al., 2009; Skaug et al., 2013). Both
oxidative stress and inﬂammation, present in arterial aging, seem to
cause alterations in the nitric oxide signalling pathway and/or a de-
creased nitric oxide bioavailability, and cause an age-related decrease
in endothelium dependent dilation (Celermajer et al., 1994; Parker
et al., 2006; Dick et al., 2009; Donato et al., 2015; Seals et al., 2011).
This could have resulted in a smaller diﬀerence in endothelial function
between groups, for which we opted to correct.
5. Conclusion
Several years after gestation, women with a history of PE have de-
creased endothelial function as measured by ﬂow mediated dilatation.
The decreased FMD does neither relate to decreased glomerular ﬁltra-
tion rate nor to micro albuminuria.
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